NCNA NuCana plc Stock Quote

NCNA [NASD]

Healthcare | Biotechnology | United Kingdom

Index	-	P/E	-	EPS (ttm)	-0.97	Insider Own	0.35%	Shs Outstand	52.18M	Perf Week	-0.32%
Market Cap	31.05M	Forward P/E	-	EPS next Y	-53.83	Insider Trans	0.00%	Shs Float	51.66M	Perf Month	-29.82%
Income	-50.50M	PEG	-	EPS next Q	-16.35	Inst Own	29.80%	Short Float	0.80%	Perf Quarter	-78.52%
Sales	-	P/S	-	EPS this Y	3.80%	Inst Trans	-28.23%	Short Ratio	0.83	Perf Half Y	-77.63%
Book/sh	1.57	P/B	0.38	EPS next Y	-11.20%	ROA	-45.00%	Target Price	9.20	Perf Year	-80.80%
Cash/sh	1.44	P/C	0.41	EPS next 5Y	-	ROE	-50.90%	52W Range	0.52 - 3.35	Perf YTD	-75.00%
Dividend	-	P/FCF	-	EPS past 5Y	-31.80%	ROI	-	52W High	-81.49%	Beta	0.62
Dividend %	-	Quick Ratio	6.10	Sales past 5Y	-	Gross Margin	-	52W Low	19.90%	ATR	0.06
Employees	31	Current Ratio	6.10	Sales Q/Q	-	Oper. Margin	-	RSI (14)	32.96	Volatility	7.86% 10.07%
Optionable	No	Debt/Eq	0.01	EPS Q/Q	-9.30%	Profit Margin	-	Rel Volume	0.27	Prev Close	0.60
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Apr 27 AMC	Payout	-	Avg Volume	496.84K	Price	0.62
Recom	1.40	SMA20	-3.37%	SMA50	-25.72%	SMA200	-69.93%	Volume	132,477	Change	4.18%

Mar-03-22

Downgrade

Cowen

Outperform → Market Perform

Oct-22-20

Initiated

Truist

Buy

$22

Jul-24-20

Initiated

Oppenheimer

Outperform

Aug-19-19

Initiated

H.C. Wainwright

Buy

$20

Oct-19-18

Initiated

Piper Jaffray

Overweight

Oct-23-17

Initiated

William Blair

Outperform

Oct-23-17

Initiated

Jefferies

Buy

$25

Oct-23-17

Initiated

Citigroup

Buy

$23

May-06-22 07:59AM	We Think NuCana (NASDAQ:NCNA) Needs To Drive Business Growth Carefully Simply Wall St.
Apr-27-22 04:01PM	NuCana Reports Fourth Quarter and Year Ended 2021 Financial Results and Provides Business Update GlobeNewswire
Mar-15-22 11:09AM	BioNTech (BNTX) to Report Q4 Earnings: What's in the Cards? Zacks +11.04%
Mar-08-22 04:35PM	NuCana Announces Upcoming Presentations on NUC-3373 at the American Association for Cancer Research (AACR) Annual Meeting 2022 GlobeNewswire -8.66%
Mar-04-22 10:00AM	Down 57.3% in 4 Weeks, Here's Why You Should You Buy the Dip in NuCana PLC Sponsored ADR (NCNA) Zacks -20.55%
Mar-03-22 06:13AM	Why Did NuCana Stop Phase 3 Biliary Tract Cancer Trial? Benzinga -59.18%
Mar-02-22 04:01PM	NuCana Announces Update for Phase 3 Biliary Tract Cancer Study GlobeNewswire
Feb-28-22 04:01PM	NuCana to Participate in Two Upcoming Investor Conferences GlobeNewswire
Feb-22-22 04:01PM	NuCana Announces Enrollment of Required Number of Patients to Conduct Second Interim Analysis in the Phase III Biliary Tract Cancer Study GlobeNewswire
Feb-01-22 10:53AM	What You Need To Know About NuCana plc's (NASDAQ:NCNA) Investor Composition Simply Wall St. +5.26%
Jan-24-22 09:40AM	Is NuCana PLC Sponsored ADR (NCNA) Outperforming Other Medical Stocks This Year? Zacks
Dec-28-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... GuruFocus.com -5.33%
Dec-21-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... GuruFocus.com
Dec-16-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... GuruFocus.com
Dec-08-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... GuruFocus.com
Nov-18-21 04:01PM	NuCana Reports Third Quarter 2021 Financial Results and Provides Business Update GlobeNewswire
Nov-10-21 08:00AM	NuCana to Present at the Jefferies 2021 London Healthcare Conference GlobeNewswire -5.05%
Nov-01-21 04:01PM	NuCana Appoints Elliott M. Levy, M.D. to its Board of Directors GlobeNewswire
01:17PM	Here's Why We're Not At All Concerned With NuCana's (NASDAQ:NCNA) Cash Burn Situation Simply Wall St.
Sep-30-21 10:18AM	Company News for Sep 30, 2021 Zacks -7.19%
Sep-29-21 12:20PM	Mid-Day Market Update: Nasdaq Edges Lower; NuCana Shares Jump Benzinga +17.30%
12:09PM	33 Stocks Moving In Wednesday's Mid-Day Session Benzinga
08:00AM	NuCana Receives Fast Track Designation from the U.S. Food and Drug Administration for Acelarin® (NUC-1031) for the Treatment of Biliary Tract Cancer GlobeNewswire
04:46AM	NuCana Soars as FDA Fast Tracks Potential Drug for Biliary Tract Cancer Investing.com
Sep-16-21 08:00AM	NuCana Announces Four Poster Presentations at the ESMO Congress 2021 GlobeNewswire
Sep-15-21 08:00AM	NuCana Announces Enrollment of Required Number of Patients to Conduct First Interim Analysis in the Phase III Biliary Tract Cancer Study GlobeNewswire
Sep-01-21 08:00AM	NuCana to Participate in Three Upcoming Investor Conferences GlobeNewswire
Aug-19-21 04:01PM	NuCana Reports Second Quarter 2021 Financial Results and Provides Business Update GlobeNewswire
Aug-10-21 08:00AM	NuCana Appoints Jeffrey D. Bloss, M.D. as Chief Medical Officer GlobeNewswire
Aug-02-21 07:11AM	Are Institutions Heavily Invested In NuCana plc's (NASDAQ:NCNA) Shares? Simply Wall St.
May-25-21 08:00AM	NuCana to Present at the Jefferies Virtual Healthcare Conference GlobeNewswire
May-19-21 04:01PM	NuCana Reports First Quarter 2021 Financial Results and Provides Business Update GlobeNewswire
May-03-21 07:42AM	Companies Like NuCana (NASDAQ:NCNA) Are In A Position To Invest In Growth Simply Wall St.
Apr-28-21 08:00AM	NuCana to Participate in the 7th Annual Truist Securities Life Sciences Summit GlobeNewswire +5.81%
Apr-10-21 08:30AM	NuCana Announces Five Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021 GlobeNewswire
Mar-04-21 04:01PM	NuCana Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Business Update GlobeNewswire -8.10%
Feb-25-21 08:00AM	NuCana to Participate in Three Upcoming Investor Conferences GlobeNewswire
Feb-01-21 05:19AM	What Is The Ownership Structure Like For NuCana plc (NASDAQ:NCNA)? Simply Wall St.
Jan-15-21 08:01AM	NuCana Presents Encouraging Data at ASCO GI for NUC-3373 in Heavily Pre-Treated Patients with Metastatic Colorectal Cancer GlobeNewswire +7.69%
Jan-12-21 11:39AM	These 2 Penny Stocks Could Surge Over 300%, Say Analysts TipRanks +17.62%
Jan-11-21 08:46AM	NuCana (NCNA) Looks Good: Stock Adds 5.7% in Session Zacks -6.00%
Dec-21-20 04:01PM	NuCana Appoints Andrew Kay as Board Chairman GlobeNewswire
Dec-07-20 11:03PM	Is NCNA A Good Stock To Buy Now? Insider Monkey
Dec-01-20 08:08AM	The Daily Biotech Pulse: Pfizer, BioNTech File Marketing Application In Europe, NuCana Jumps On Data, Amarin Takes On Hikma In Patent Lawsuit Benzinga
Nov-30-20 04:01PM	Final Data from the Phase Ib Study of Acelarin plus Cisplatin in Patients with Advanced Biliary Tract Cancer Published Online Ahead of Print in The Oncologist GlobeNewswire
Nov-19-20 04:01PM	NuCana Reports Third Quarter 2020 Financial Results and Provides Business Update GlobeNewswire
Nov-17-20 04:01PM	NuCana to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference GlobeNewswire
Nov-12-20 04:01PM	NuCana to Present at the Jefferies Virtual London Healthcare Conference GlobeNewswire
Nov-10-20 08:59AM	Why NuCana (NCNA) Might Surprise This Earnings Season Zacks
Nov-03-20 08:16AM	Companies Like NuCana (NASDAQ:NCNA) Are In A Position To Invest In Growth Simply Wall St.
Oct-13-20 04:01PM	NuCana Expands its Board of Directors with the Appointment of Bali Muralidhar GlobeNewswire
Oct-02-20 08:00PM	Metacrine, Prelude Therapeutics See Activist Action Barrons.com
Sep-24-20 08:31AM	NuCana (NCNA) Surges: Stock Moves 6.3% Higher Zacks
Sep-21-20 04:02PM	NuCana Presents Three Posters at the ESMO Virtual Congress 2020 GlobeNewswire -6.16%
04:01PM	NuCana Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters Option to Purchase Additional American Depositary Shares GlobeNewswire
Sep-17-20 07:00AM	NuCana Announces Pricing of a Public Offering of American Depositary Shares GlobeNewswire -19.51%
Sep-16-20 04:01PM	NuCana Announces Proposed Public Offering of American Depositary Shares GlobeNewswire
Aug-19-20 04:01PM	NuCana Reports Second Quarter 2020 Financial Results and Provides Business Update GlobeNewswire
Aug-18-20 09:46AM	Should You Buy NuCana (NCNA) Ahead of Earnings? Zacks
Aug-05-20 09:10AM	What Kind Of Shareholders Hold The Majority In NuCana plc's (NASDAQ:NCNA) Shares? Simply Wall St.
Jul-31-20 12:34PM	Oppenheimer: These 3 Strong Buy Stocks Have Over 50% Upside Potential TipRanks +5.92%
Jul-24-20 03:25PM	Benzinga's Top Upgrades, Downgrades For July 24, 2020 Benzinga +8.93%
Jul-02-20 12:25PM	Blueprint Medicines Files NDA to FDA for Pralsetinib in MTC Zacks
Jun-29-20 12:49PM	Axsome's AXS-05 Gets Breakthrough Therapy Tag for AD Agitation Zacks
Jun-24-20 11:53AM	Gilead to Buy 49.9% Stake in Private Biotech for $275M Zacks
Jun-18-20 10:23AM	Protagonist Therapeutics' PTG-300 Gets FDA's Orphan Drug Tag Zacks
Jun-16-20 10:47AM	ACADIA Files sNDA for Nuplazid in Dementia-Related Psychosis Zacks
Jun-10-20 01:04PM	Immunic Gets FDA Allowance for Phase II Coronavirus Study Zacks
Jun-02-20 08:59AM	Why NuCana (NCNA) Stock Might be a Great Pick Zacks
Jun-01-20 12:20PM	Will NuCana Continue to Surge Higher? Zacks
May-28-20 10:54AM	Top Ranked Momentum Stocks to Buy for May 28th Zacks
May-27-20 09:34AM	5 Health Care Stocks to Bet on as Coronavirus Woes Linger Zacks +5.91%
07:00AM	NuCana to Present at the 2020 Jefferies Virtual Healthcare Conference GlobeNewswire
May-24-20 07:00AM	3 Strong Buy Healthcare Stocks That Could Double in the Next Year TipRanks
May-19-20 04:01PM	NuCana Reports First Quarter 2020 Financial Results and Provides Business Update GlobeNewswire
May-18-20 07:00AM	NuCana Announces the Re-Opening of Enrollment in Multiple Clinical Studies After Temporary Pause Due to COVID-19 Pandemic GlobeNewswire +6.52%
May-15-20 07:00AM	NuCana to Present Two Abstracts at the American Association for Cancer Research (AACR) Annual Meeting 2020 GlobeNewswire
May-05-20 04:01PM	NuCana Announces Re-Opening of Global Phase III Study of Acelarin Plus Cisplatin in Patients with Biliary Tract Cancer (NuTide:121) GlobeNewswire
Apr-02-20 04:01PM	NuCana Provides Update on Impact of COVID-19 on Clinical Studies GlobeNewswire -9.65%
Mar-18-20 08:25AM	NuCana (NASDAQ:NCNA) Is In A Good Position To Deliver On Growth Plans Simply Wall St. -23.85%
Mar-11-20 08:03AM	The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment Benzinga -6.21%
Mar-10-20 04:02PM	NuCana Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Business Update GlobeNewswire
04:01PM	NuCana Reports Preliminary Data from Phase II Study of Single-Agent Acelarin (NUC-1031) in Patients with Platinum-Resistant Ovarian Cancer GlobeNewswire
Mar-04-20 07:00AM	NuCana Receives Positive Opinion for Orphan Drug Designation in the European Union for Acelarin (NUC-1031) for the Treatment of Patients with Biliary Tract Cancer GlobeNewswire +15.29%
Feb-29-20 07:00AM	Harvard Sold Facebook, Palo Alto Stock. Heres What It Bought. Barrons.com
Feb-25-20 09:46AM	NuCana (NCNA) to Report Q4 Earnings: What's in the Cards? Zacks -7.22%
07:00AM	NuCana to Present at the Cowen and Company 40th Annual Health Care Conference GlobeNewswire
Jan-27-20 07:00AM	NuCana Announces First Patients Dosed in Both US and Europe in Phase III Study of Acelarin (NUC-1031) for the First-Line Treatment of Patients with Biliary Tract Cancer GlobeNewswire +7.63%
Jan-03-20 10:54AM	Innate Pharma's Filing for Leukemia Drug Accepted in Europe Zacks
Dec-20-19 05:44PM	NuCana plc (NCNA): Are Hedge Funds Right About This Stock? Insider Monkey -6.44%
Dec-11-19 07:04AM	New Strong Buy Stocks for December 11th Zacks +7.94%
Nov-27-19 03:32AM	Sorrento Turns Down Two All-Cash Takeover Bids, Stock Jumps Zacks
Nov-26-19 07:00AM	NuCana to Participate in the Piper Jaffray 31st Annual Healthcare Conference GlobeNewswire
Nov-22-19 10:48AM	3 Strong Buy Stocks Set for Triple Digit Gains TipRanks +6.13%
Nov-20-19 09:50AM	Achillion's (ACHN) Danicopan Gets EMA's PRIME Tag for PNH Zacks
Nov-14-19 07:00AM	NuCana to Present at the Jefferies 2019 London Healthcare Conference GlobeNewswire
Nov-13-19 04:01PM	NuCana Reports Third Quarter 2019 Financial Results and Provides Business Update GlobeNewswire
Oct-29-19 07:00AM	NuCana Presents Data at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics GlobeNewswire -5.20%
Oct-25-19 07:00AM	NuCana Announces FDA Clearance to Commence Phase III Study of Acelarin (NUC-1031) for the First-Line Treatment of Patients with Biliary Tract Cancer GlobeNewswire
Oct-17-19 11:24AM	Lilly's Pancreatic Cancer Candidate Fails in Phase III Study Zacks +5.72%

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients with recurrent ovarian cancer; Phase III clinical trials for the treatment of patients with biliary tract cancer; Phase II clinical trial for the treatment of patients with platinum-resistant ovarian cancer; and Phase III clinical trial for the treatment of patients with metastatic pancreatic cancer. The company is also developing NUC-3373, a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil, which is in Phase I clinical trial for the treatment of patients with advanced solid tumors; and NUC-7738, a nucleoside analog that is in Phase I clinical trial for the treatment of patients with advanced solid tumors and hematological tumors. NuCana plc has a research, collaboration, and license agreement with Cardiff University and University College Cardiff Consultants Ltd. for the design, synthesis, characterization, and evaluation of ProTides; and an assignment, license, and collaboration agreement with Cardiff ProTides Ltd. The company was formerly known as NuCana BioMed Limited and changed its name to NuCana plc in August 2017. NuCana plc was incorporated in 1997 and is headquartered in Edinburgh, the United Kingdom.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience